- Home
- CZNC vs SWKH Comparison
CZNC vs SWKH Comparison
Compare CZNC & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- SWKH
- Stock Information
- Founded
- CZNC 1864
- SWKH 1996
- Country
- CZNC United States
- SWKH United States
- Employees
- CZNC N/A
- SWKH N/A
- Industry
- CZNC Major Banks
- SWKH Diversified Financial Services
- Sector
- CZNC Finance
- SWKH Finance
- Exchange
- CZNC Nasdaq
- SWKH Nasdaq
- Market Cap
- CZNC 299.8M
- SWKH 214.3M
- IPO Year
- CZNC N/A
- SWKH 1999
- Fundamental
- Price
- CZNC $18.56
- SWKH $17.10
- Analyst Decision
- CZNC
- SWKH
- Analyst Count
- CZNC 0
- SWKH 0
- Target Price
- CZNC N/A
- SWKH N/A
- AVG Volume (30 Days)
- CZNC 16.3K
- SWKH 10.9K
- Earning Date
- CZNC 10-17-2024
- SWKH 08-15-2024
- Dividend Yield
- CZNC 6.03%
- SWKH N/A
- EPS Growth
- CZNC N/A
- SWKH N/A
- EPS
- CZNC 1.51
- SWKH 0.94
- Revenue
- CZNC $103,194,000.00
- SWKH $25,767,000.00
- Revenue This Year
- CZNC N/A
- SWKH N/A
- Revenue Next Year
- CZNC $6.19
- SWKH $6.17
- P/E Ratio
- CZNC $12.29
- SWKH $18.21
- Revenue Growth
- CZNC 1.34
- SWKH N/A
- 52 Week Low
- CZNC $16.50
- SWKH $15.40
- 52 Week High
- CZNC $23.50
- SWKH $18.75
- Technical
- Relative Strength Index (RSI)
- CZNC 42.52
- SWKH 47.67
- Support Level
- CZNC $19.16
- SWKH $16.76
- Resistance Level
- CZNC $19.69
- SWKH $17.60
- Average True Range (ATR)
- CZNC 0.49
- SWKH 0.31
- MACD
- CZNC -0.09
- SWKH -0.04
- Stochastic Oscillator
- CZNC 0.00
- SWKH 34.00
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.